Alterity Therapeutics (ATHE) Short Interest Ratio & Short Volume → Democrats Push to Replace Dollar With Digital Coin, Control Currency. (From Monetary Gold) (Ad) Free ATHE Stock Alerts $2.02 -0.02 (-0.98%) (As of 05/16/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial Media Alterity Therapeutics Short Interest DataCurrent Short Volume85,900 sharesPrevious Short Volume90,300 sharesChange Vs. Previous Month-4.87%Dollar Volume Sold Short$179,960.50Short Interest Ratio / Days to Cover1.1Last Record DateApril 30, 2024Outstanding Shares4,670,000 sharesFloat Size8,330,000 sharesShort Percent of Float1.03%Today's Trading Volume24,492 sharesAverage Trading Volume50,489 sharesToday's Volume Vs. Average49% Short Selling Alterity Therapeutics ? Sign up to receive the latest short interest report for Alterity Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatATHE Short Interest Over TimeATHE Days to Cover Over TimeATHE Percentage of Float Shorted Over Time Ad Monetary GoldDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.This means you must act NOW before it's too late. Alterity Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202485,900 shares $179,960.50 -4.9%1.0%1.1 $2.10 4/15/202490,300 shares $221,235.00 +290.9%1.1%1.1 $2.45 3/31/202423,100 shares $47,817.00 -12.5%0.3%0.6 $2.07 3/15/202426,400 shares $46,464.00 +47.5%0.3%0.6 $1.76 2/29/202417,900 shares $33,473.00 -52.7%0.2%0.3 $1.87 2/15/202437,800 shares $76,356.00 +25.6%0.5%0.1 $2.02 Get the Latest News and Ratings for ATHE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alterity Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/202430,100 shares $63,511.00 +85.8%N/A0 $2.11 1/15/202416,200 shares $30,780.00 -77.0%0.3%0 $1.90 12/31/202370,500 shares $175,545.00 +22.8%1.2%0.1 $2.49 12/15/202357,400 shares $173,922.00 +12.6%1.3%0.1 $3.03 11/30/202351,000 shares $92,310.00 +684.6%1.2%0.1 $1.81 11/15/20236,500 shares $15,925.00 -11.0%0.2%1.2 $2.45 10/31/20237,300 shares $17,022.14 -32.4%0.2%2.6 $2.33 10/15/202310,800 shares $26,244.00 -12.9%0.3%3.4 $2.43 9/30/202312,400 shares $30,752.00 -13.3%0.3%3.2 $2.48 9/15/202314,300 shares $37,180.00 -14.4%0.4%3.6 $2.60 8/31/202316,700 shares $45,257.00 -13.0%0.4%3.9 $2.71 8/15/202319,200 shares $54,528.00 +12.9%0.5%4 $2.84 7/31/202317,000 shares $49,300.00 +54.6%0.4%3.7 $2.90 7/15/202311,000 shares $31,128.90 +15.8%0.3%2.3 $2.83 6/30/20239,500 shares $26,505.00 -41.7%0.2%2.2 $2.79 6/15/202316,300 shares $47,107.00 +6.5%0.4%2.3 $2.89 5/31/202315,300 shares $44,523.00 +1.3%0.4%0.9 $2.91 5/15/202315,100 shares $43,790.00 +0.7%0.4%0.9 $2.90 4/30/202315,000 shares $41,998.50 -35.3%0.4%0.7 $2.80 4/15/202323,200 shares $66,816.00 -27.3%0.6%1 $2.88 3/31/202331,900 shares $88,682.00 +423.0%0.8%1.1 $2.78 3/15/20236,100 shares $15,921.00 -14.1%0.2%0.2 $2.61 2/28/20237,100 shares $22,791.00 +6.0%0.2%0.4 $3.21 2/15/20236,700 shares $20,167.00 -22.1%0.2%0.4 $3.01 1/31/20238,600 shares $33,626.00 -34.4%0.2%0.5 $3.91 1/15/202313,100 shares $54,365.00 +10.1%0.3%1 $4.15 12/30/202211,900 shares $41,435.80 -90.5%N/A1.1 $3.48 12/15/2022125,500 shares $40,172.55 -3.9%N/A2.2 $0.32 11/30/2022130,600 shares $47,329.44 -15.3%N/A1.5 $0.36 11/15/2022154,100 shares $61,640.00 -33.1%N/A1.6 $0.40 10/31/2022230,200 shares $90,445.58 -6.9%N/A2.3 $0.39 10/15/2022247,200 shares $113,687.28 -2.4%N/A2.3 $0.46 9/30/2022253,200 shares $111,433.32 -4.3%N/A2.3 $0.44 9/15/2022264,700 shares $153,472.80 +22.5%N/A2.3 $0.58Tech GIANT’s Plans to Revolutionize Crypto… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. ATHE Short Interest - Frequently Asked Questions What is Alterity Therapeutics' current short interest? Short interest is the volume of Alterity Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 85,900 shares of ATHE short. 1.03% of Alterity Therapeutics' shares are currently sold short. Learn More on Alterity Therapeutics' current short interest. What is a good short interest ratio for Alterity Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ATHE shares currently have a short interest ratio of 1.0. Learn More on Alterity Therapeutics's short interest ratio. What is a good short interest percentage for Alterity Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.03% of Alterity Therapeutics' floating shares are currently sold short. Is Alterity Therapeutics' short interest increasing or decreasing? Alterity Therapeutics saw a decrease in short interest in April. As of April 30th, there was short interest totaling 85,900 shares, a decrease of 4.9% from the previous total of 90,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Alterity Therapeutics' float size? Alterity Therapeutics currently has issued a total of 4,671,000 shares. Some of Alterity Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Alterity Therapeutics currently has a public float of 8,330,000 shares. How does Alterity Therapeutics' short interest compare to its competitors? 1.03% of Alterity Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Alterity Therapeutics: Molecular Templates, Inc. (4.68%), NuCana plc (1.21%), Chemomab Therapeutics Ltd. (0.98%), Addex Therapeutics Ltd (1.85%), Galera Therapeutics, Inc. (7.34%), Aeterna Zentaris Inc. (0.34%), Guardion Health Sciences, Inc. (14.33%), Moleculin Biotech, Inc. (1.45%), MIRA Pharmaceuticals, Inc. (0.42%), Avalo Therapeutics, Inc. (10.13%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Alterity Therapeutics stock? Short selling ATHE is an investing strategy that aims to generate trading profit from Alterity Therapeutics as its price is falling. ATHE shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Alterity Therapeutics? A short squeeze for Alterity Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ATHE, which in turn drives the price of the stock up even further. How often is Alterity Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ATHE, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Molecular Templates Short Interest Data NuCana Short Interest Data Chemomab Therapeutics Short Interest Data Addex Therapeutics Short Interest Data Galera Therapeutics Short Interest Data Aeterna Zentaris Short Interest Data Guardion Health Sciences Short Interest Data Moleculin Biotech Short Interest Data MIRA Pharmaceuticals Short Interest Data Avalo Therapeutics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ATHE) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDoes this make you sick?Allegiance GoldWhy Is Gold On a MASSIVE rally? Huge AlertsUrgent Alert: Is the U.S. Implementing a Digital Dollar?Gold Gate Capital348 million Americans lives to END as we know it?The Oxford ClubBiden Nomination CANCELED?The Freeport SocietyGold Set to EXPLODE!Gold Safe ExchangeDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary Gold